Biosimilar Regulatory Update

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Immuron Limited SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: Australia, South Africa, Canada, World

Global Oncology Biosimilars Market 2014-2018

Global Oncology Biosimilars Market 2014-2018

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • November 2014
  • 71 pages

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars ...

Industries: Biopharmaceutical | Countries: World

iBio, Inc. - Product Pipeline Review - 2014

iBio, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 51 pages

iBio, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘iBio, Inc. - Product Pipeline Review - 2014', provides an overview of the iBio, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental ...

Industries: Biopharmaceutical | Countries: World

Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014

Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 20 pages

Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Eiger BioPharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive ...

Industries: Biopharmaceutical | Countries: World

IC - Michael Uren Biomedical Engineering Hub - London - Construction Project Profile

IC - Michael Uren Biomedical Engineering Hub - London - Construction Project Profile

  • $ 75
  • Company report
  • by World Market Intelligence Ltd
  • November 2014
  • 8 pages

Synopsis The "IC - Michael Uren Biomedical Engineering Hub - London" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key ...

Industries: Biopharmaceutical | Countries: World

Indoor Location Market by Solution, by Application (Indoor Maps & Navigation, Indoor Location-based Analytics, Tracking & Tracing, Monitoring & Emergency Management), by Service, by Vertical, & by Region - Global Forecast Up to 2019

Indoor Location Market by Solution, by Application (Indoor Maps & Navigation, Indoor Location-based Analytics, Tracking & Tracing, Monitoring & Emergency Management), by Service, by Vertical, & by Region - Global Forecast Up to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • November 2014
  • 149 pages

In recent years, there has been a substantial demand for indoor positioning and navigation equipment in the marketplace across verticals. The demand is surging in those industries that were early indoor location adopters. With potential opportunities in emerging verticals, there is a good investment ...

Industries: Biopharmaceutical | Countries: World, North America, Europe

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • November 2014
  • 157 pages

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment ...

Industries: Biopharmaceutical | Countries: World, Europe, North America

Global Antibody Drug Conjugate Market Outlook 2018

Global Antibody Drug Conjugate Market Outlook 2018

  • $ 1 200
  • Industry report
  • by RNCOS
  • November 2014
  • 50 pages

For more than a century, the concept of a “magic bullet” to deliver cytotoxic therapy to the site of tumor has been envisioned, but only recently the technological advances enabled antibody-drug conjugates to fulfill that dream. The recent approvals of ADCETRIS and Kadcyla followed by various ADCs ...

Industries: Biopharmaceutical | Countries: World, United States

Gut and Digestive Health Ingredients and Consumer Products - Market Trends and Insights

Gut and Digestive Health Ingredients and Consumer Products - Market Trends and Insights

  • $ 3 495
  • Industry report
  • by Canadean Ltd
  • October 2014
  • 44 pages

Summary Millions of consumers are facing gut and digestive health disorders which provides business opportunities for dietary supplement producers looking to provide effective products that can help manage illness and intolerances, as well as promote overall health. Global demand for probiotics is predicted ...

Industries: Nutraceutical, Biopharmaceutical | Countries: World

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • October 2014
  • 27 pages

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014', provides an overview of the Asklepios BioPharmaceutical, Inc.'s pharmaceutical research and development focus. This report provides ...

Industries: Biopharmaceutical | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 514 2762

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.